DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
De Bono JS, Oudard S, Ozguroglu M. et al.
Prednisone plus Cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.
Lancet 2010;
376: 1147-1154
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.